Key Players: Perkinelmer, Danaher Corporation, Biotek Instruments, Tecan Group
High Content Screening Market by type 2017-2022 by new Service spreads across 166 pages profiling 10 companies and supported with 138 tables and 42 figures available at ReportsandReports.com
Get Sample Copy for Professional Insights @ www.reportsnreports.com/contacts/r…aspx?name=274849
The global high-content screening (HCS) market is projected to reach USD 909.0 million by 2022 at a CAGR of 10.3% during the forecast period. The factors expected to drive the growth of the market are cost containment in pharmaceutical R&D, increasing funding for cellular research, and technological advancements in HCS solutions during the forecast period.
The rapid growth in developing countries across APAC is also expected to provide an opportunity for revenue generation in the market. However, the high cost of HCS instruments and the dearth of knowledgeable and skilled personnel for the operation of the instruments are expected to restrain the market growth to a certain extent.
The HCS instruments market accounted for the largest share of HCS market primarily attributed to advances in instrumentation and automation techniques and high prices of the HCS instruments. The software segment is expected to register the highest growth during the forecast period.
The growth of this market is attributed to the technological advancements in image acquisition, data analysis, and storage capabilities and the need to obtain information on changes in cell morphology through high-quality images.
North America is the largest market for high-content screening, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. High R&D expenditure, the presence of major pharmaceutical market players, and increasing government support are some of the factors contributing to the large share of North America in the market.
However, the Asia-Pacific market is expected to register the highest growth during the forecast period owing to increased research in drug discovery, government initiatives, growing focus of multinational companies on emerging markets, and developing R&D infrastructure.
Complete Browse Here@ www.reportsnreports.com/reports/27…orecasts-to.html
Global High-Content Screening Market, By Product
Cell Imaging and Analysis Systems
Reagents & Assay Kits
Global High-Content Screening Market, By Application
Primary and Secondary Screening
Target Identification and Validation
Key Players from Table of Content
12 Company Profiles
(Overview, Products and Services, Financials, Strategy & Development)*
12.2 GE Healthcare
12.3 Danaher Corporation
12.4 Perkinelmer, Inc.
12.5 Thermo Fisher Scientific Inc.
12.6 Becton, Dickinson and Company
12.7 Biotek Instruments, Inc.
12.8 Bio-Rad Laboratories, Inc.
12.9 Tecan Group Ltd.
12.10 Yokogawa Electric Corporation
12.11 Merck Millipore
*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.